You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenomyoepithelioma

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Clear Cell Carcinoma Trial (Zimberelimab, Metformin Hydrochloride)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • (no location specified)
Feb 25, 2023

Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 26, 2023

Ovarian Clear Cell Carcinoma Trial (Camrelizumab)

Not yet recruiting
  • Ovarian Clear Cell Carcinoma
  • (no location specified)
Oct 29, 2022

Ovarian Clear Cell Carcinoma, Gynecologic Cancer Trial in Boston (Lenvatinib, Pembrolizumab)

Recruiting
  • Ovarian Clear Cell Carcinoma
  • Gynecologic Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 13, 2022

Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

Active, not recruiting
  • Renal Clear Cell Carcinoma
  • Renal Papillary Cell Carcinoma
  • London, United Kingdom
    Thomas Powles
Aug 10, 2022

Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

Not yet recruiting
  • Ovarian Neoplasms
  • +5 more
  • (no location specified)
Sep 3, 2023

Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • (no location specified)
May 14, 2023

Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

Recruiting
  • Nasopharyngeal Carcinoma
  • +8 more
  • Springdale, Arkansas
    Highlands Oncology
Nov 11, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Chicago, Providence (Nivolumab, Ipilimumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 26, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (3 cycles chemo instead of 6 cycles chemo, 6 cycles

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • 3 cycles chemotherapy instead of 6 cycles chemotherapy
  • 6 cycles chemotherapy
  • (no location specified)
Jul 12, 2022

Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

Recruiting
  • Kidney Cancer
  • +11 more
  • 13C-Glucose
  • +4 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Clinicopathologic and Ancillary Testing of Primary Clear Cell

Recruiting
  • Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type
  • Electronic Health Record Review
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Sep 13, 2021

Ovarian Clear Cell Carcinoma Trial in Wuhan (Sintilimab, Bevacizumab Biosimilar IBI305)

Recruiting
  • Ovarian Clear Cell Carcinoma
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Apr 18, 2022

Ovarian Cancer, Recurrent Cancer Trial (CYH33)

Not yet recruiting
  • Ovarian Cancer
  • Recurrent Cancer
  • (no location specified)
Sep 5, 2021

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

ID TCRs From Renal Clear Cell Carcinoma Patients Responding to

Withdrawn
  • Renal Clear Cell Carcinoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 19, 2021

    Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)

    Active, not recruiting
    • Uterine Cancer
    • +6 more
    • Basking Ridge, New Jersey
    • +7 more
    Apr 4, 2022

    Asian Multicenter Prospective Study of ctDNA Sequencing

    Recruiting
    • Cervical Cancer
    • +5 more
    • NGS analysis of ctDNA
    • Tokyo, Japan
    • +18 more
    Sep 28, 2022

    MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

    Active, not recruiting
    • MSI-H Colorectal Cancer
    • +30 more
    • Badalona, Barcelona, Spain
    • +9 more
    Oct 24, 2022

    Endometrioid Adenocarcinoma, Serous Carcinoma, Clear Cell Carcinoma Trial in London (Image-guided adjuvant pelvic radiotherapy)

    Recruiting
    • Endometrioid Adenocarcinoma
    • +4 more
    • Image-guided adjuvant pelvic radiotherapy
    • London, Ontario, Canada
      London Regional Cancer Program
    Sep 2, 2020

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Germany (Rucaparib, Placebos)

    Recruiting
    • Ovarian Cancer
    • +3 more
    • Berlin, Germany
    • +22 more
    Aug 30, 2021

    Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)

    Completed
    • Ewing Sarcoma
    • +12 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 14, 2020

    Renal Cell Carcinoma (RCC), Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in United States (CDX-014)

    Terminated
    • Renal Cell Carcinoma (RCC)
    • +5 more
    • Scottsdale, Arizona
    • +4 more
    Jun 2, 2020